Supplemental Figure 1 from Association of Leukocyte Mitochondrial DNA Copy Number with Colorectal Cancer Risk: Results from the Shanghai Women's Health Study

Bo Huang,Yu-Tang Gao,Xiao-Ou Shu,Wanqing Wen,Gong Yang,Guoliang Li,Regina Courtney,Bu-Tian Ji,Hong-Lan Li,Mark P. Purdue,Wei Zheng,Qiuyin Cai

DOI: https://doi.org/10.1158/1055-9965.22436011

2023-01-01

Abstract:<p>Representative PCR amplification plots and standard curves.</p>

What problem does this paper attempt to address?

Abstract 1126: Mitochondrial DNA Copy Number and Colorectal Cancer Risk: Results from the Shanghai Women's Health Study

Bo Huang,Yu-Tang Gao,Xiao Ou Shu,Wanqing Wen,Gong Yang,Guoliang Li,Bu-Tian Ji,Hong-Lan Li,Wong-Ho Chow,Wei Zheng,Qiuyin Cai

DOI: https://doi.org/10.1158/1538-7445.am2012-1126

IF: 11.2

2012-01-01

Cancer Research

Abstract:Abstract Mitochondria play an important role in cellular energy metabolism, free radical generation, and apoptosis. Cumulative evidence suggests that mtDNA copy number may be a biomarker for cancer risk. Using a nested case-control design, we evaluated mtDNA copy number in peripheral blood cells in relation to colorectal cancer risk. Included in the study were 436 colorectal cancer cases and 881 matched controls identified from the Shanghai Woman's Health Study, a population-based, prospective cohort study conducted among Chinese women. Relative mtDNA copy number was determined in triplicate by a quantitative real-time PCR assay using peripheral blood cell DNA samples collected at the time of study enrollment, prior to cancer diagnosis. Baseline levels of mtDNA copy number were lower among women who subsequently developed colorectal cancer (geometric mean = 0.271, 95% CI: 0.263-0.279) than those who remained cancer-free (geometric mean = 0.281, 95% CI: 0.275-0.288) (P=0.0274). Multivariate adjusted odds ratios were 1.15 (95% CI: 0.80-1.65), 1.12 (95% CI: 0.78-1.60) and 1.58 (95% CI: 1.10-2.26) for third to the first quartile of mtDNA copy numbers, respectively, comparing with the highest quartile (P for trend = 0.0135). The association varied little by the interval between blood draw and cancer diagnosis. To our knowledge, this is the first large prospective study evaluating the association of mtDNA copy number with subsequent risk of developing colorectal cancer. Our data suggests that decreased mtDNA copy number may be associated with increased colorectal cancer risk, and mtDNA copy number measured in peripheral blood cells may be a potential biomarker useful for colorectal cancer risk assessment. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1126. doi:1538-7445.AM2012-1126
Supplementary Figure 1 from Inherited Variants in Mitochondrial Biogenesis Genes May Influence Epithelial Ovarian Cancer Risk

Jennifer Permuth-Wey,Y. Ann Chen,Ya-Yu Tsai,Zhihua Chen,Xiaotao Qu,Johnathan M. Lancaster,Heather Stockwell,Getachew Dagne,Edwin Iversen,Harvey Risch,Jill Barnholtz-Sloan,Julie M. Cunningham,Robert A. Vierkant,Brooke L. Fridley,Rebecca Sutphen,John McLaughlin,Steven A. Narod,Ellen L. Goode,Joellen M. Schildkraut,David Fenstermacher,Catherine M. Phelan,Thomas A. Sellers

DOI: https://doi.org/10.1158/1055-9965.22435387.v1

2023-01-01

Abstract:Supplementary Figure 1 from Inherited Variants in Mitochondrial Biogenesis Genes May Influence Epithelial Ovarian Cancer Risk
Supplementary Figures 1-2, Tables 1-8 from Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis

Xueying Mao,Yongwei Yu,Lara K. Boyd,Guoping Ren,Dongmei Lin,Tracy Chaplin,Sakunthala C. Kudahetti,Elzbieta Stankiewicz,Liyan Xue,Luis Beltran,Manu Gupta,R. Tim D. Oliver,Nick R. Lemoine,Daniel M. Berney,Bryan D. Young,Yong-Jie Lu

DOI: https://doi.org/10.1158/0008-5472.22383381.v1

2023-01-01

Abstract:Supplementary Figures 1-2, Tables 1-8 from Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis
Supplementary Figure S10 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Wenju Chang,Zhou Zhang,Baoqing Jia,Kefeng Ding,Zhizhong Pan,Guoqiang Su,Wei Zhang,Tianyu Liu,Yunshi Zhong,Guodong He,Li Ren,Ye Wei,Dongdong Li,Xiaolong Cui,Jun Yang,Yixiang Shi,Marc Bissonnette,Chuan He,Wei Zhang,Jia Fan,Jianmin Xu

DOI: https://doi.org/10.1158/1078-0432.26423000

2024-01-01

Abstract:The interaction and/or co-modification modules identified from the candidate marker genes.
Mitochondrial DNA copy number and risk of gastric cancer: A report from the Shanghai women's health study

Linda M Liao,Andrea A. Baccarelli,Xiao-Ou Shu,Yu Tang Gao,Bu-Tian Ji,Gong Yang,Hong-Lan Li,Mirjam Hoxha,Laura Dioni,Nathaniel Rothman,Wei Zheng,Wongho Chow -

DOI: https://doi.org/10.1158/1055-9965.EPI-11-0379

2011-01-01

Cancer Epidemiology Biomarkers & Prevention

Abstract:Background: Mitochondrial DNA (mtDNA) is an approximately 16,000-bp circular double-stranded DNA molecule that is a prime target of oxidative damage. Several somatic mutations in mtDNA have been observed in gastric tumors, suggesting an involvement in gastric cancer risk and progression. mtDNA copy number in leukocyte DNA has also been linked to several other cancers, although the temporal relationship between mtDNA and cancer has not been adequately explored. Methods: Using a nested case-control study design, we examined the association between mtDNA copy number in 162 gastric cancer cases and 299 matched controls within the Shanghai Women's Health Study, a large population-based prospective cohort. Relative mtDNA copy number was measured in triplicate by a quantitative real-time PCR assay in peripheral leukocytes. Results: mtDNA copy number levels were comparable among cases and controls, with a median of 1.04 [interquartile range (IQR), 0.87-1.25] and 1.06 (IQR, 0.88-1.29), respectively. Overall, mtDNA was not associated with gastric cancer risk. However, the association differed when stratified by the time between sample collection and cancer diagnosis. An association between low levels of mtDNA copy number (<median) and gastric cancer risk was apparent among earlier diagnosed cases, in particular, those diagnosed within 2 years of sample collection (OR = 5.32; 95% CI = 1.03-27.60). This association was not present as the time between sample collection and cancer diagnosis increased. Conclusions and Impact: Our findings suggest that there is no association between leukocyte mtDNA copy number and risk of developing gastric cancer; however, we observed a possible early disease effect on mtDNA copy number levels. Cancer Epidemiol Biomarkers Prev; 20(9); 1944-9. (C)2011 AACR.
Supplemental Table 1 from Mitochondrial DNA Content As Risk Factor for Bladder Cancer and Its Association with Mitochondrial DNA Polymorphisms

S. B. Williams,Yuanqing Ye,Maosheng Huang,David W. Chang,Ashish M. Kamat,Ximing Pu,Colin P.N. Dinney,Xifeng Wu

DOI: https://doi.org/10.1158/1940-6207.22525530

2023-01-01

Abstract:Supplemental Table 1. Association of bladder cancer with mtDNA copy number stratified by gender
Supplementary Figure 1 from Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15Q24-25.1

Yan Liu,Pengyuan Liu,Weidong Wen,Michael A. James,Yian Wang,Joan E. Bailey-Wilson,Christopher I. Amos,Susan M. Pinney,Ping Yang,Mariza de Andrade,Gloria M. Petersen,Jonathan S. Wiest,Pamela R. Fain,Ann G. Schwartz,Adi Gazdar,Colette Gaba,Henry Rothschild,Diptasri Mandal,Elena Kupert,Juwon Lee,Daniela Seminara,John Minna,Marshall W. Anderson,Ming You

DOI: https://doi.org/10.1158/0008-5472.22382063

2023-01-01

Abstract:Supplementary Figure 1 from Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15q24-25.1
Association between mitochondrial DNA content in leukocytes and colorectal cancer risk

Falin Qu,Xiaonan Liu,Feng Zhou,Hushan Yang,Guoqiang Bao,Xianli He,Jinliang Xing

DOI: https://doi.org/10.1002/cncr.25906

IF: 6.9209

2011-01-01

Cancer

Abstract:BACKGROUND: Compelling epidemiological evidence indicated that alterations of mitochondria! DNA (mtDNA), including mutations and abnormal content of mtDNA, were implicated in the tumorigenesis of several malignancies in a tumor-specific manner, such as lung cancer, breast cancer, and non-Hodgkin lymphoma. This study was undertaken to investigate whether mtDNA content in peripheral blood lymphocytes (PBLs) could be used as a risk predictor for colorectal cancer (CRC). METHODS: The mtDNA content was measured by using quantitative real-time polymerase chain reaction in PBLs from 320 CRC patients and 320 matched controls. RESULTS: The authors found that CRC patients exhibited statistically significantly higher mtDNA content than matched controls (median, 1.03 vs.86; P < .001). They further assessed the association between mtDNA content and CRC risk using multivariate logistic regression. By using the median value in controls as the cutoff point, they found that, compared with low mtDNA content, high mtDNA content was associated with a significantly increased CRC risk (adjusted odds ratio, 2.03; 95% confidence interval, 1.41-2.81). In a trend analysis, they found a statistically significant dose-response relationship between higher mtDNA content and increased CRC risk (P for trend <.001). Stratified analysis showed that the association between mtDNA content and CRC risk was not modulated by major host characteristics. CONCLUSIONS: These findings provide the first epidemiological evidence linking the high mtDNA content in PBLs to elevated CRC risk. Cancer 2011;117:3148-55. (C) 2011 American Cancer Society.
The Analysis for Identifying Large DNA Fragment Aberrations of MSH2 and MLH1 Genes from Familial Colorectal Cancer in China

Ming Zhu,Xiao-rong Liu,Yan-qin Huang,Ying Yuan,Jin-tian Li,Xiao-mei Zhang,Yuan-ying Zhang,Ya-ping Wang

DOI: https://doi.org/10.3760/j.issn:1003-9406.2005.06.002

2005-01-01

Abstract:OBJECTIVE:To investigate the frequency of large fragment aberrations of MSH2 and MLH1 genes from Chinese colorectal cancer (CRC) patients with family history.METHODS:Sixteen exons of MSH2, nineteen exons of MLH1 and seven DNA sequences from the other genes of the samples were screened and checked by multiplex ligation dependent probe amplification (MLPA). First, the methodology was confirmed by testing the positive and negative control samples. Then, 32 CRC or hereditary nonpolyposis colorectal cancer (HNPCC) patients with family history and 20 cases of sporadic CRC were applied to investigate for the large fragment aberrations of MSH2 and MLH1 genes.RESULTS:The genomic DNA fragment deletions of all positive controls were identified and verified by MLPA. Three cases of 32 familial (hereditary) CRC/HNPCC were detected and identified to be the germline heterozygous deletions of MSH2 gene, of which exons 1-7 were deleted from patient No.3, exon 11 from No.25 and exons 2-6 from No.11. However, no genomic DNA fragment aberration of either MSH2 or MLH1 gene was uncovered from 20 sporadic CRC.CONCLUSION:Large DNA fragment aberrations of MSH2 gene was a frequent cause of Chinese HNPCC and CRC patients with family history, and the identification of those aberrations should be included in the regular genetic analysis for CRC/HNPCC patients.
Pooled Analysis of Mitochondrial DNA Copy Number and Lung Cancer Risk in Three Prospective Studies

Christopher Kim,Bryan A. Bassig,Wei Jie Seow,Wei Hu,Mark P. Purdue,Xiao-Ou Shu,Wen-Yi Huang,Chin-San Liu,Wen-Ling Cheng,Ta-Tsung Lin,Yong-Bing Xiang,Bu-Tian Ji,Yu-Tang Gao,Wong-Ho Chow,Satu Maennistoe,Stephanie J. Weinstein,Demetrius Albanes,Wei Zheng,H. Dean Hosgood,Unhee Lim,Nathaniel Rothman,Qing Lan

DOI: https://doi.org/10.1158/1055-9965.epi-14-1070

2014-01-01

Cancer Epidemiology Biomarkers & Prevention

Abstract:Background: We previously reported that higher levels of mitochondrial DNA copy number (mtDNA CN) were associated with lung cancer risk among male heavy smokers (i.e., >= 20 cigarettes per day) in the Alpha-Tocopherol Beta-Carotene (ATBC) study. Here, we present two additional prospective investigations nested in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial and the Shanghai Women's Health Study (SWHS), and pooled with previously published data from ATBC.Materials: All DNA were extracted from peripheral whole blood samples using the phenol-chloroform method, and mtDNA CN was assayed by fluorescence-based qPCR. Multivariate unconditional logistic regression models were used to estimate ORs and 95% confidence intervals for the association of mtDNA CN and lung cancer risk.Results: Overall, mtDNA CN was not associated with lung cancer risk in the PLCO, SWHS, or pooled populations (all P trends > 0.42, P heterogeneity = 0.0001), and mtDNA CN was inversely associated with lung cancer risk among male smokers in PLCO, the opposite direction observed in ATBC. In addition, the mtDNA CN association observed among male heavy smokers in ATBC was the opposite direction in PLCO.Conclusions: mtDNA CN was not consistently associated with lung cancer risk across three prospective study populations from Europe, Asia, and the United States.Impact: This pooled study suggests no consistent association between prediagnostic mtDNA CN levels and lung cancer risk across several populations. (C) 2014 AACR.
Supplementary Table S4 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Wenju Chang,Zhou Zhang,Baoqing Jia,Kefeng Ding,Zhizhong Pan,Guoqiang Su,Wei Zhang,Tianyu Liu,Yunshi Zhong,Guodong He,Li Ren,Ye Wei,Dongdong Li,Xiaolong Cui,Jun Yang,Yixiang Shi,Marc Bissonnette,Chuan He,Wei Zhang,Jia Fan,Jianmin Xu

DOI: https://doi.org/10.1158/1078-0432.26422958.v1

2024-01-01

Abstract:Differetially modified gene bodies between CRC/AA and controls.
Supplementary Table S3 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Wenju Chang,Zhou Zhang,Baoqing Jia,Kefeng Ding,Zhizhong Pan,Guoqiang Su,Wei Zhang,Tianyu Liu,Yunshi Zhong,Guodong He,Li Ren,Ye Wei,Dongdong Li,Xiaolong Cui,Jun Yang,Yixiang Shi,Marc Bissonnette,Chuan He,Wei Zhang,Jia Fan,Jianmin Xu

DOI: https://doi.org/10.1158/1078-0432.26422961.v1

2024-01-01

Abstract:Participant characteristics of 80 patients with other cancers.
Association of Mitochondrial DNA Displacement Loop (ca)n Dinucleotide Repeat Polymorphism with Breast Cancer Risk and Survival among Chinese Women.

Chuanzhong Ye,Yu-Tang Gao,Wanqing Wen,Joan P. Breyer,Xiao Ou Shu,Jeffrey R. Smith,Wei Zheng,Qiuyin Cail

DOI: https://doi.org/10.1158/1055-9965.epi-07-2798

2008-01-01

Cancer Epidemiology Biomarkers & Prevention

Abstract:Mitochondrial genome alternations may be involved in carcinogenesis. The noncoding region of the mitochondrial DNA (mtDNA) displacement loop (D-loop) has emerged as a mutational hotspot. Using data from a population-based case-control study conducted among Chinese women in Shanghai, we evaluated associations of breast cancer risk and survival with the mtDNA D-loop (CA)n dinucleotide repeat polymorphism. Included in the study were 1,058 cases and 1,129 age frequency–matched community controls that participated in the Shanghai Breast Cancer Study between 1996 and 1998. Breast cancer patients were followed to determine intervals of overall survival and disease-free survival. Overall, there was no association between the mtDNA D-loop (CA)n repeat polymorphism and breast cancer risk. Patients with multiple alleles of the mtDNA D-loop (CA)n polymorphism (heteroplasmy) had significantly poorer disease-free survival than those with one allele of the mtDNA D-loop (CA)n polymorphism (hazard ratio 1.62; 95% confidence interval, 1.16-2.26). These results suggest that the mtDNA D-loop (CA)n repeat polymorphism may be associated with breast cancer survival. Additional studies with a larger sample size are warranted. (Cancer Epidemiol Biomarkers Prev 2008;17(8):2117–22)
Supporting Figure 2 from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

Yunping Qiu,Guoxiang Cai,Bingsen Zhou,Dan Li,Aihua Zhao,Guoxiang Xie,Houkai Li,Sanjun Cai,Dong Xie,Changzhi Huang,Weiting Ge,Zhanxiang Zhou,Lisa X. Xu,Weiping Jia,Shu Zheng,Yun Yen,Wei Jia

DOI: https://doi.org/10.1158/1078-0432.22449230

2023-01-01

Abstract:PDF file 126K, PCA and OPLS-DA scores plot for CRC samples and adjacent non-tumor tissues collected from Hangzhou, Beijing and City of Hope
Supplementary Information from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

Yunping Qiu,Guoxiang Cai,Bingsen Zhou,Dan Li,Aihua Zhao,Gary Xie,Houkai Li,Sanjun Cai,Dong Xie,Changzhi Huang,Weiting Ge,Zhanxiang Zhou,Lisa X. Xu,Jia Wang,Shusen Zheng,Yun Yen

DOI: https://doi.org/10.1158/1078-0432.22449236.v1

2023-01-01

Abstract:PDF file 119K, This file includes supplementary text and figure legends for supporting figures
Figure 2 from Exploring the Complex Relationship between Gut Microbiota and Risk of Colorectal Neoplasia Using Bidirectional Mendelian Randomization Analysis

Wanxin Li,Xuan Zhou,Shuai Yuan,Lijuan Wang,Lili Yu,Jing Sun,Jie Chen,Qian Xiao,Zhongxiao Wan,Ju-Sheng Zheng,Cai-Xia Zhang,Susanna C. Larsson,Susan M. Farrington,Philip Law,Richard S. Houlston,Ian Tomlinson,Ke-Feng Ding,Malcolm G. Dunlop,Evropi Theodoratou,Xue Li

DOI: https://doi.org/10.1158/1055-9965.23275149

2023-01-01

Abstract:Effects of genetic liability to adenoma on Gammaproteobacteria from MiBioGen consortium. A and C, Forest plot for summarizing the results of all MR methods and heterogeneity tests of IVW and MR-PRESSO. B, Scatter plot for comparison of MR methods. Abbreviations: Q-test, Cochran's Q statistic heterogeneity test. MR-PRESSO, MR pleiotropy residual sum and outlier test.
Table S4 from Exploring the Complex Relationship Between Gut Microbiota and Risk of Colorectal Neoplasia Using Bidirectional Mendelian Randomization Analysis

Wanxin Li,Xuan Zhou,Shuai Yuan,Lijuan Wang,Lili Yu,Jing Sun,Jie Chen,Qian Xiao,Zhongxiao Wan,Ju-Sheng Zheng,Cai-Xia Zhang,Susanna C. Larsson,Susan M. Farrington,Philip Law,Richard S. Houlston,Ian Tomlinson,Ke-Feng Ding,Malcolm G. Dunlop,Evropi Theodoratou,Xue Li

DOI: https://doi.org/10.1158/1055-9965.22658591

2023-01-01

Abstract:Table S4 shows the SNPs for colorectal cancer.
Supplementary Figures 1-2, Tables 1-6 from Genetic Variants on Chromosome 15q25 Associated with Lung Cancer Risk in Chinese Populations

Chen Wu,Zhibin Hu,Dianke Yu,Liming Huang,Guangfu Jin,Jie Liang,Huan Guo,Wen Tan,Mingfeng Zhang,Ji Qian,Daru Lu,Tangchun Wu,Dongxin Lin,Hongbing Shen

DOI: https://doi.org/10.1158/0008-5472.22377476.v1

2023-01-01

Abstract:Supplementary Figures 1-2, Tables 1-6 from Genetic Variants on Chromosome 15q25 Associated with Lung Cancer Risk in Chinese Populations
Mitochondrial DNA copy number and cancer risks: A comprehensive Mendelian randomization analysis

Xianlei Cai,Chao Liang,Miaozun Zhang,Zhebin Dong,Yihui Weng,Weiming Yu

DOI: https://doi.org/10.1002/ijc.34833

2024-04-15

Abstract:Mitochondrial DNA plays a critical role in the pathophysiology of cancer. However, the associations between mitochondrial DNA copy number (mtDNA-CN) and cancer risk are controversial. Mendelian randomization (MR) analyses were performed using three independent instrumental variables (IVs) to explore potential associations between mtDNA-CN and 20 types of cancer. The three sets of IVs were primarily obtained from participants in the UK Biobank and the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium using different methods. The outcome data of cancers were investigated using summary statistics from the FinnGen cohort. The potential causal associations were evaluated using the MR-Egger regression, weighted median, inverse-variance weighted (IVW), and weighted mode methods. The robustness of IVW estimates was validated using leave-one-out sensitivity analysis. Additionally, a meta-analysis was conducted to pool results from three sets of IVs. The results revealed that genetically predicted mtDNA-CN was not associated with cancer risk (odds ratio = 1.02; 95% confidence interval: 0.95-1.10). Subgroup analyses indicated no causal association between mtDNA-CN and breast, lung, prostate, skin, colorectal, gastric, liver, cervical uteri, esophageal, thyroid, bladder, pancreas, kidney, corpus uteri, ovary, brain, larynx, and anus cancers. It was observed that mtDNA-CN was associated with lip, oral cavity, and testis cancers. However, these results should be interpreted with caution because a small number of patients with lip and oral cavity or testis cancers were included. The comprehensive MR analysis demonstrated that mtDNA-CN is not a suitable biomarker for tumor risk assessment.
Supplementary Figure 8 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Lingling Li,Dongxian Jiang,Hui Liu,Chunmei Guo,Qiao Zhang,Xuedong Li,Xiaojian Chen,Zheqi Chen,Jinwen Feng,Subei Tan,Wen Huang,Jie Huang,Chen Xu,Chen-Ying Liu,Wei Yu,Yingyong Hou,Chen Ding

DOI: https://doi.org/10.1158/0008-5472.26934673.v1

2024-01-01

Abstract:Supplementary Figure 8 and related legend of the revised manuscript.

Supplemental Figure 1 from Association of Leukocyte Mitochondrial DNA Copy Number with Colorectal Cancer Risk: Results from the Shanghai Women's Health Study

Abstract 1126: Mitochondrial DNA Copy Number and Colorectal Cancer Risk: Results from the Shanghai Women's Health Study

Supplementary Figure 1 from Inherited Variants in Mitochondrial Biogenesis Genes May Influence Epithelial Ovarian Cancer Risk

Supplementary Figures 1-2, Tables 1-8 from Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis

Supplementary Figure S10 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Mitochondrial DNA copy number and risk of gastric cancer: A report from the Shanghai women's health study

Supplemental Table 1 from Mitochondrial DNA Content As Risk Factor for Bladder Cancer and Its Association with Mitochondrial DNA Polymorphisms

Supplementary Figure 1 from Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15Q24-25.1

Association between mitochondrial DNA content in leukocytes and colorectal cancer risk

The Analysis for Identifying Large DNA Fragment Aberrations of MSH2 and MLH1 Genes from Familial Colorectal Cancer in China

Pooled Analysis of Mitochondrial DNA Copy Number and Lung Cancer Risk in Three Prospective Studies

Supplementary Table S4 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Supplementary Table S3 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Association of Mitochondrial DNA Displacement Loop (ca)n Dinucleotide Repeat Polymorphism with Breast Cancer Risk and Survival among Chinese Women.

Supporting Figure 2 from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

Supplementary Information from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

Figure 2 from Exploring the Complex Relationship between Gut Microbiota and Risk of Colorectal Neoplasia Using Bidirectional Mendelian Randomization Analysis

Table S4 from Exploring the Complex Relationship Between Gut Microbiota and Risk of Colorectal Neoplasia Using Bidirectional Mendelian Randomization Analysis

Supplementary Figures 1-2, Tables 1-6 from Genetic Variants on Chromosome 15q25 Associated with Lung Cancer Risk in Chinese Populations

Mitochondrial DNA copy number and cancer risks: A comprehensive Mendelian randomization analysis

Supplementary Figure 8 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression